OMEGACHOICE^® + COQSOURCE^® was invented by SourceOne’s multidisciplinary team of medical professionals, pharmacists, and natural product industry leaders to address cardiovascular health risks and promote ultimate longevity while dramatically reducing the food and fat dependency to achieve optimal bioavailability of these two key ingredients.

It is well established in the medical community that omega-3 essential fatty acids (EFAs) and coenzyme Q10 are two of the most researched ingredients for overall heart health. Omega-3 EFAs have extensive health benefits, particularly associated with cardiovascular health and cognitive function. According to the Mayo Clinic and the American Heart Association, evidence suggests that recommended amounts of Omega-3 Fatty Acids slow the buildup of plaque, lower triglycerides, and support healthy blood pressure thereby reducing the risk factors for heart disease. CoQ10 is required by every cell in the body for energy production and antioxidant protection. The human heart has massively high energy requirements to function normally which is why CoQ10 is one of the most sought after ingredients for a healthy cardiovascular system. It is also used as an antioxidant to combat against oxidative stress - in effect, improving healthy cholesterol levels.

Unfortunately, CoQ10 has very low aqueous solubility and a relatively high molecular weight, rendering it poorly bioavailable after oral administration. In addition, omega-3 EFAs are known to be heavily food dependent for oral absorption and bioavailability. To overcome these limitations, SourceOne leverages the VESIsorb® delivery system, therefore achieving industry benchmarks for unprecedented active loading, improved bioavailability, and mitigating food dependency.

Human clinical trials have demonstrated the dramatic improvement in oral bioavailability of these two, science-backed ingredients in both well-designed Phase I study (Pharma, Omega-3 EPA) and peer-reviewed published study (Nutritional, CoQ10) for VESIsorb® formulations. Moreover, the food dependency of the VESIsorb® formulation was significantly mitigated.

Improved bioavailability directly translates to delivering higher blood plasma levels with a much lower dose.

‍The benefits are unmatched:

- Faster onset, independent of food/fat status.

- Fewer servings required to achieved the desired therapeutic effect.

- Superior loading for smaller and easier to consumer capsules.

- Addressing issues related to poor absorption like age, diet, and gender.

Simply put, this is the only formula ever created to achieve high bioavailable doses of 500 mg of omega-3 EFAs and 100 mg of CoQ10 in one softgel capsule.